Martin E. Evans
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 32
- Clostridium difficile and Clostridium perfringens research 24
- Epidemiology 30
- Microscopic Colitis 9
- Co-authors
- Robert P. Rapp (11 shared papers)David J. Feola (1 shared paper)William Schaffner (4 shared papers)D. W. Gregory (2 shared papers)Z. A. McGee (2 shared papers)Gary A. Roselle (23 shared papers)Stephen M. Kralovic (19 shared papers)Loretta A. Simbartl (23 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (29 papers)American Journal of Infection Control (9 papers)Clinical Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Annals of Pharmacotherapy (6 papers)
- Partner nations
- United StatesAustraliaUganda
In The Last Decade
Martin E. Evans
91 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 137
- Applied Microbiology and Biotechnology 449
- Molecular Medicine 707
- Clinical Biochemistry 466
- Infectious Diseases 1.1k
- Critical Care and Intensive Care Medicine 277
Countries citing papers authored by Martin E. Evans
This map shows the geographic impact of Martin E. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Evans more than expected).
Fields of papers citing papers by Martin E. Evans
This network shows the impact of papers produced by Martin E. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Evans. The network helps show where Martin E. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin E. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 443 | |
| 2 | 2011 | 374 | |
| 3 | Tularemia: a 30-year experience with 88 cases. | 1985 | 230 |
| 4 | 1985 | 199 | |
| 5 | 1993 | 88 | |
| 6 | 2005 | 81 | |
| 7 | 2001 | 75 | |
| 8 | 1988 | 73 | |
| 9 | 1996 | 65 | |
| 10 | 2004 | 55 | |
| 11 | 1997 | 53 | |
| 12 | 2005 | 47 | |
| 13 | 2004 | 47 | |
| 14 | 2014 | 44 | |
| 15 | 1996 | 44 | |
| 16 | 2004 | 43 | |
| 17 | 2005 | 42 | |
| 18 | 2014 | 36 | |
| 19 | 1985 | 36 | |
| 20 | 2016 | 35 |
About Martin E. Evans
Martin E. Evans is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 96 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (32 papers), Clostridium difficile and Clostridium perfringens research (24 papers), Antibiotic Use and Resistance (22 papers), Antibiotic Resistance in Bacteria (21 papers), Nosocomial Infections in ICU (17 papers), Bacterial Identification and Susceptibility Testing (17 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Microscopic Colitis (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (449 citations), Molecular Medicine (707 citations), Clinical Biochemistry (466 citations), Infectious Diseases (1.1k citations) and Critical Care and Intensive Care Medicine (277 citations). Martin E. Evans has collaborated with scholars based in United States, Australia and Uganda. Frequent co-authors include Robert P. Rapp, David J. Feola, William Schaffner, D. W. Gregory, Z. A. McGee, Gary A. Roselle, Stephen M. Kralovic, Loretta A. Simbartl, Rajiv Jain and Matthew Pollack. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.